SMT (Sahajanand Medical Technologies), the leading manufacturer of cardiac stents in India, announces a strategic partnership with Cordis, Cardinal Health’s interventional vascular business. 

The new partnership with SMT in India will provide Cardinal Health access to the fast-growing Indian cardiology market, as the latter marks its entry into the Indian market.

SMT has a strong and established sales and direct distribution network across India including Tier II & III cities.

Through this partnership, the Cordis range of products would be made available to patients across the country.

Collaboration between Cardinal Health and SMT will address the high disease burden of cardiac mortality and hospitalizations in India, by providing global quality cardiology and endovascular solutions to hospitals and patients.

The new partnership with Cardinal Health will provide best in class products in cardio access, endo-access, cardiac guide catheter and PTCA balloons segment.

SMT will take up this basket of quality products to the fast-growing Indian cardiology market with a strong and established sales and direct distribution network across India including Tier II & III cities.

This will help Indian patients to have access to world class products in cardiovascular segment.

Through this partnership, Cardinal Health will be able to build reliable and efficient channels to reach deep into the Indian market for Cordis products.